Literature DB >> 21912408

Stroke: TIA-is ABCD2 useful in choosing who, what, where and when?

Jonathan A Edlow.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21912408     DOI： 10.1038/nrneurol.2011.140

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

1.  Potential and failure of the ABCD2 score in stroke risk prediction after transient ischemic attack.

Authors:  Georgios Tsivgoulis; Ioannis Heliopoulos
Journal:  Stroke       Date:  2010-03-18       Impact factor: 7.914

2.  Population-based study of ABCD2 score, carotid stenosis, and atrial fibrillation for early stroke prediction after transient ischemic attack: the North Dublin TIA study.

Authors:  Orla C Sheehan; Lorraine Kyne; Lisa A Kelly; Niamh Hannon; Michael Marnane; Aine Merwick; Patricia M E McCormack; Joseph Duggan; Alan Moore; Joan Moroney; Leslie Daly; Dawn Harris; Gillian Horgan; Emma B Williams; Peter J Kelly
Journal:  Stroke       Date:  2010-03-18       Impact factor: 7.914

3.  Impact of an emergency department observation unit transient ischemic attack protocol on length of stay and cost.

Authors:  Fadi Nahab; George Leach; Carlene Kingston; Osman Mir; Jerome Abramson; Sarah Hilton; Matthew Keadey; Bryce Gartland; Michael Ross
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-04-09       Impact factor: 2.136

4.  Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack.

Authors:  Jeffrey J Perry; Mukul Sharma; Marco L A Sivilotti; Jane Sutherland; Cheryl Symington; Andrew Worster; Marcel Émond; Grant Stotts; Albert Y Jin; Weislaw J Oczkowski; Demetrios J Sahlas; Heather E Murray; Ariane MacKey; Steve Verreault; George A Wells; Ian G Stiell
Journal:  CMAJ       Date:  2011-06-06       Impact factor: 8.262

5.  What do we mean by validating a prognostic model?

Authors:  D G Altman; P Royston
Journal:  Stat Med       Date:  2000-02-29       Impact factor: 2.373

6.  Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison.

Authors:  Peter M Rothwell; Matthew F Giles; Arvind Chandratheva; Lars Marquardt; Olivia Geraghty; Jessica N E Redgrave; Caroline E Lovelock; Lucy E Binney; Linda M Bull; Fiona C Cuthbertson; Sarah J V Welch; Shelley Bosch; Faye C Alexander; Faye Carasco-Alexander; Louise E Silver; Sergei A Gutnikov; Ziyah Mehta
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

Review 7.  Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.

Authors:  J Donald Easton; Jeffrey L Saver; Gregory W Albers; Mark J Alberts; Seemant Chaturvedi; Edward Feldmann; Thomas S Hatsukami; Randall T Higashida; S Claiborne Johnston; Chelsea S Kidwell; Helmi L Lutsep; Elaine Miller; Ralph L Sacco
Journal:  Stroke       Date:  2009-05-07       Impact factor: 7.914

8.  Does ABCD2 score below 4 allow more time to evaluate patients with a transient ischemic attack?

Authors:  Pierre Amarenco; Julien Labreuche; Philippa C Lavallée; Elena Meseguer; Lucie Cabrejo; Tarik Slaoui; Céline Guidoux; Jean-Marc Olivot; Halim Abboud; Bertrand Lapergue; Isabelle F Klein; Mikael Mazighi; Pierre-Jean Touboul
Journal:  Stroke       Date:  2009-06-11       Impact factor: 7.914

9.  Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack.

Authors:  S Claiborne Johnston; Peter M Rothwell; Mai N Nguyen-Huynh; Matthew F Giles; Jacob S Elkins; Allan L Bernstein; Stephen Sidney
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.